664
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Why are new antidepressants failing to make the grade for approval?

Pages 641-643 | Received 20 Feb 2017, Accepted 21 Mar 2017, Published online: 03 Apr 2017
 

Acknowledgment

The author thanks Jacquie Klesing, Board-certified Editor in the Life Sciences (ELS), for editing assistance with the manuscript. Ms. Klesing has no conflicts of interest to declare.

Declaration of interest

In the last three years HJ Möller has received honoraria for lectures or expert meetings from the following pharmaceutical companies: Lilly, Lundbeck, Schwabe, and Servier. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.